Application 204790

Type
NDA
Sponsor
VIIV HLTHCARE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TIVICAYDOLUTEGRAVIR SODIUMTABLET;ORALEQ 50MG BASEYesYes
002TIVICAYDOLUTEGRAVIR SODIUMTABLET;ORALEQ 10MG BASEYesNo
003TIVICAYDOLUTEGRAVIR SODIUMTABLET;ORALEQ 25MG BASEYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
49702-226Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-226Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-226Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-226Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-226Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-226Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-226Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-226Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-226Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-226Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-227Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-227Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-227Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-227Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-227Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-227Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-227Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-227Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-227Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-227Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-228Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-228Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-228Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-228Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-228Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-228Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-228Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-228Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-228Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
49702-228Tivicaydolutegravir sodiumViiV Healthcare CompanyNDACurrent
50090-1355Tivicaydolutegravir sodiumA-S Medication SolutionsNDACurrent
53808-1130Tivicaydolutegravir sodiumDOH CENTRAL PHARMACYNDACurrent
67296-1818Tivicaydolutegravir sodiumRedPharm Drug, Inc.NDACurrent
70518-1487Tivicaydolutegravir sodiumREMEDYREPACK INC.NDACurrent
70518-1487Tivicaydolutegravir sodiumREMEDYREPACK INC.NDACurrent
70518-1487Tivicaydolutegravir sodiumREMEDYREPACK INC.NDACurrent
70518-1487Tivicaydolutegravir sodiumREMEDYREPACK INC.NDACurrent
70518-1487Tivicaydolutegravir sodiumREMEDYREPACK INC.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83982SUPPL 2025-10-29
83975SUPPL 2025-10-29
78170SUPPL 2024-04-19
78161SUPPL 2024-04-19
72298SUPPL2022-10-11
72285SUPPL2022-10-11
68062SUPPL2021-07-13
68050SUPPL2021-07-12
66863SUPPL2021-03-25
66855SUPPL2021-03-24
63573SUPPL2020-06-16
63565SUPPL2020-06-15
62331SUPPL2020-03-25
62325SUPPL2020-03-25
60691SUPPL2019-10-28
60668SUPPL2019-10-25
55444SUPPL2018-09-12
55443SUPPL2018-09-12
55417SUPPL2018-09-10
55416SUPPL2018-09-10
50499SUPPL2017-11-27
50480SUPPL2017-11-24
47763SUPPL2017-03-29
47734SUPPL2017-03-28
32593SUPPL2016-06-10
19602SUPPL2016-06-10
40423SUPPL2016-04-29
32592SUPPL2016-04-26
10396SUPPL2015-08-10
19601SUPPL2015-08-07
19600SUPPL2015-01-08
32591SUPPL2014-12-24
40422SUPPL2014-05-13
32590SUPPL2014-05-13
43479ORIG2013-09-13
24481ORIG2013-09-13
10395ORIG2013-08-20
19599ORIG2013-08-19
54054SUPPL1900-01-01
52619SUPPL1900-01-01
52618SUPPL1900-01-01
52616ORIG1900-01-01
52615ORIG1900-01-01
52614ORIG1900-01-01